Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis

Stefano Gelibter; Marco Pisa; Tommaso Croese; Annamaria Finardi; Alessandra Mandelli; Francesca Sangalli; Bruno Colombo; Vittorio Martinelli; Gıancarlo Comı; Massimo Filippi; Roberto Furlan

doi:10.1002/ana.26154

Abstract

1 min read

Our results confirm that CSF myeloid microvesicles are a clinically meaningful biomarker of neuroinflammation and microglial/macrophage activity in vivo. These findings may support a possible use in clinical practice during diagnostic workup and prognostic assessment. ANN NEUROL 2021;90:253-265.

Related publications

Article2020

CHIT1 at Diagnosis Reflects Long‐Term Multiple Sclerosis Disease Activity

Emanuela Oldoni, Ide Smets, Klara Mallants, Marijne Vandebergh, Lies Van Horebeek, Koen Poesen, Patrick Dupont, Bénédicte Dubois, An Goris

Article2013

Microglial Microvesicles: Useful Prognostic Tool for Mild Cognitive Impairment and Alzheimer Disease Patients (P03.079)

Dacia Dalla Libera, Federica Agosta, Edoardo Spinelli, Alessandra Bergami, Giuseppe Magnani, Michela Matteoli, Claudia Verderio, Gıancarlo Comı, Massimo Filippi, Roberto Furlan

Article2016

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis

Anna M. Pietroboni, Francesca Schiano di Cola, Marta Scarioni, Chiara Fenoglio, Barbara Spanò, Andrea Arighi, Sara Cioffi, Emanuela Oldoni, Milena De Riz, Paola Basilico, Alberto Calvi, Giorgio Fumagalli, Fabio Triulzi, Daniela Galimberti, Marco Bozzali, Elio Scarpini

Article2011

MR Imaging of Multiple Sclerosis

Massimo Filippi, Maria A. Rocca

Article2018

CSF β-amyloid predicts prognosis in patients with multiple sclerosis

Anna M. Pietroboni, Michela Caprioli, Tiziana Carandini, Marta Scarioni, Laura Ghezzi, Andrea Arighi, Sara Cioffi, Claudia Cinnante, Chiara Fenoglio, Emanuela Oldoni, Milena De Riz, Paola Basilico, Giorgio Fumagalli, Annalisa Colombi, Giovanni Giulietti, Laura Serra, Fabio Triulzi, Marco Bozzali, Elio Scarpini, Daniela Galimberti